(Q45740040)

English

Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens. Triest Cohort Investigators

scientific article published on 25 October 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens. Triest Cohort Investigators (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Willy Rozenbaum

9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

Girard PM

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Guiguet M

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Bollens D

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Goderel I

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Meyohas MC

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Lecomte I

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Raguin G

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Frottier J

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Jaillon P

10

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

language of work or name

0 references

publication date

25 October 2000

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

987-994

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F318154

21 January 2018

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1086%2F318154

21 January 2018

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1086%2F318154

21 January 2018

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F318154

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1086%2F318154

21 January 2018

Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group

1 reference

https://api.crossref.org/works/10.1086%2F318154

21 January 2018

Combination antiretroviral therapy and recent declines in AIDS incidence and mortality

1 reference

https://api.crossref.org/works/10.1086%2F318154

21 January 2018

The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV Medicine.

1 reference

https://api.crossref.org/works/10.1086%2F318154

21 January 2018

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

1 reference

https://api.crossref.org/works/10.1086%2F318154

21 January 2018

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1086%2F318154

21 January 2018

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1086%2F318154

21 January 2018

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

1 reference

https://api.crossref.org/works/10.1086%2F318154

21 January 2018

Virological response to protease inhibitor therapy in an HIV clinic cohort.

1 reference

https://api.crossref.org/works/10.1086%2F318154

21 January 2018

Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor

1 reference

https://api.crossref.org/works/10.1086%2F318154

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45740040&oldid=2079885104"